Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26F0WA9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $101,062
Award facts
- Contract value 100% obligated
- $101,062.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $101,062.03 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injections on October 31, 2025, with an ultimate completion date of November 3, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. This delivery order for Dupixent, a specialty pharmaceutical used in treating inflammatory conditions, exemplifies the company's role in fulfilling the DLA Troop Support Medical's comprehensive pharmaceutical supply requirements across multiple therapeutic domains. The broader SPE2DX contract vehicle enables AmerisourceBergen to supply an extensive range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities to support Defense Health Agency operations and other federal healthcare systems globally.
Quick answers
Who was awarded contract SPE2DR26F0WA9?
SPE2DR26F0WA9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DR26F0WA9 worth?
The government has obligated $101,062 on SPE2DR26F0WA9.
Is contract SPE2DR26F0WA9 an order under another contract?
Yes. SPE2DR26F0WA9 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0WA9 competed?
The extent of competition for SPE2DR26F0WA9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award